Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
The Pharma Data
NOVEMBER 15, 2020
” Arthur Oubrie, Chief Scientific Officer of Lead Pharma, added: “This is the second project we partner with one of the largest pharmaceutical companies under our Discover, Design and Deliver platform. . Lead Pharma may receive payments of up to €260 million plus royalties on sales. OSS, Netherlands , Nov.
52 
Let's personalize your content